Biora Therapeutics (BIOR) Insider Trading & Ownership $0.17 +0.02 (+10.24%) As of 01/10/2025 Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends Biora Therapeutics (NASDAQ:BIOR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage51.08%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$3,812.50 Get BIOR Insider Trade Alerts Want to know when executives and insiders are buying or selling Biora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BIOR Insider Buying and Selling by Quarter Biora Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/5/2022Surbhi SarnaDirectorSell1$3,812.50$3,812.50 (Data available from 1/1/2013 forward) BIOR Insider Trading Activity - Frequently Asked Questions Who is on Biora Therapeutics's Insider Roster? The list of insiders at Biora Therapeutics includes Surbhi Sarna. Learn more on insiders at BIOR. What percentage of Biora Therapeutics stock is owned by insiders? 51.08% of Biora Therapeutics stock is owned by insiders. Learn more on BIOR's insider holdings. Biora Therapeutics Key ExecutivesMr. Aditya P. Mohanty M.B.A. (Age 57)CEO & Director Compensation: $984.14kMr. Eric d'Esparbes (Age 56)Chief Financial Officer Compensation: $748.26kMr. Clarke Neumann J.D. (Age 60)Senior VP, General Counsel & Secretary Compensation: $724.62kEric FoxVP of Finance & Accounting & TreasurerMr. George Gianakopoulos (Age 63)Senior Vice President of Sales Ms. Robyn HattonHead of Human ResourcesMr. Kevin Howe Ph.D.Senior VP of Strategic OperationsDr. Sharat Singh Ph.D. (Age 65)Head of Research Dr. Paul Shabram M.B.A.Head of Technical OperationsMs. Ariella Kelman M.D.Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Pasithea Therapeutics Insider Buying Sunshine Biopharma Insider Buying InMed Pharmaceuticals Insider Buying Artelo Biosciences Insider Buying Qualigen Therapeutics Insider Buying Shuttle Pharmaceuticals Insider Buying Entero Therapeutics Insider Buying Alaunos Therapeutics Insider Buying Galera Therapeutics Insider Buying Processa Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher This page (NASDAQ:BIOR) was last updated on 1/13/2025 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
